Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Plc Regulatory News (ZTF)

Share Price Information for Zotefoams Plc (ZTF)

Share Price is delayed by 15 minutes
Get Live Data
446.00    3.00 (0.68%)
Bid:
439.50
Ask:
444.00
Spread: 4.50 (1.024%)
Market Cap: £219.35m
ZTF Live PriceLast checked at - London Stock Exchange

Intraday Zotefoams Plc Share Chart

Director/PDMR Shareholding

17 Oct 2017 13:08

RNS Number : 8409T
Zotefoams PLC
17 October 2017
Ā 

17 October 2017

Ā 

Zotefoams plc

Ā 

(the 'Company')

Ā 

Directors' Share Dealings

Ā 

The Company was notified on 17 October 2017 that on 16 October 2017 the following Directors became beneficially interested in the number of ordinary shares of 5 pence in the Company set out against their names in the table below under the Zotefoams Share Incentive Plan (the 'SIP'). The shares were purchased on their behalf by the SIP Trustee (Yorkshire Building Society) at a price of £3.53 per share.

Ā 

The SIP is an all-employee trust arrangement approved by HM Revenue and Customs, under which employees are able to buy ordinary shares ('partnership shares') in the Company, using deductions from salary in each monthly pay period, and receive allocations of matching free ordinary shares ('matching shares'). Dividends received on the shares held in the SIP are used to buy further ordinary shares ('dividend shares') in the Company.

Ā 

The table below sets out the number of dividend shares purchased.

Ā 

Director

No. of dividend shares purchased

Ā 

D B Stirling

8

G C McGrath

7

Ā 

Ā 

Following the above-mentioned transactions, Mr Stirling and Mr McGrath are beneficially interested in the following number of shares:

Ā 

Director

Number of shares¹

Percentage of issued Share Capital

D B Stirling

Ā 

398,411

0.90

G C McGrath

1,007

Ā 

0.00

Ā 

¹ Includes partnership shares, dividend shares and vested matching shares.

Ā 

The Notification of Dealing Form for each Director can be found below.

Ā 

This notification is made in accordance with the Market Abuse Regulation.

Ā 

Enquiries:

James Kindell

Company Secretary

Zotefoams plc

020 8664 1600

Ā 

About Zotefoams plc:

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology. Using a unique manufacturing process with environmentally friendly nitrogen expansion, Zotefoams produces and sells lightweight AZOTEĀ® polyolefin and ZOTEKĀ® high-performance foams for diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FITĀ® advanced insulation for demanding industrial markets. In addition, Zotefoams owns and licenses patented MuCellĀ® microcellular foam technology, developed specifically for extrusion applications, from a base in Massachusetts, USA to customers worldwide.

Ā 

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky and Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA (MuCell Extrusion) and Jiangsu Province, China (T-FITĀ®).

Ā 

www.zotefoams.com

Ā 

ZOTEFOAMS PLC

DEALING NOTIFICATION FORMFOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS

Ā 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: David Stirling

2.

Reason for the notification

a)

Position/status: Group CEO

b)

Initial notification/Amendment: Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Zotefoams plc

b)

LEI: 213800B6P256B5XN8D32

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 5 pence each

Identification code: GB0009896605

b)

Nature of the transaction: Purchase of dividend shares under the share incentive plan

c)

Price(s) and volume(s):

Price(s)

Volume(s)

Ā£3.53

8

d)

Aggregated information:

Ā 

Aggregate Price

Aggregate Volume

Aggregate Total

Ā£3.53

8

Ā£28.24

e)

Date of the transaction: 2017-10-16; 12:20:30

f)

Place of the transaction: XLON

Ā 

Ā 

ZOTEFOAMS PLC

DEALING NOTIFICATION FORMFOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS

Ā 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Gary McGrath

2.

Reason for the notification

a)

Position/status: Group CFO

b)

Initial notification/Amendment: Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Zotefoams plc

b)

LEI: 213800B6P256B5XN8D32

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 5 pence each

Identification code: GB0009896605

b)

Nature of the transaction: Purchase of dividend shares under the share incentive plan

c)

Price(s) and volume(s):

Price(s)

Volume(s)

Ā£3.53

7

d)

Aggregated information:

Ā 

Aggregate Price

Aggregate Volume

Aggregate Total

Ā£3.53

7

Ā£24.71

e)

Date of the transaction: 2017-10-16; 12:20:30

f)

Place of the transaction: XLON

Ā 

Ā 

This information is provided by RNS
The company news service from the London Stock Exchange
Ā 
END
Ā 
Ā 
DSHEAAEXFEKXFFF
Date   Source Headline
8th Sep 20153:56 pmRNSDirector/PDMR Shareholding
7th Aug 20159:00 amRNSDirector/PDMR Shareholding
4th Aug 20157:00 amRNSHalf Yearly Report
10th Jul 20157:00 amRNSTrading Update
9th Jul 201511:38 amRNSHolding(s) in Company
2nd Jul 20157:30 amRNSDirector Declaration
23rd Jun 20154:08 pmRNSHolding(s) in Company
22nd Jun 20154:58 pmRNSHolding(s) in Company
22nd Jun 20152:39 pmRNSHolding(s) in Company
27th May 20158:57 amRNSHolding(s) in Company
13th May 20153:00 pmRNSResult of AGM
13th May 20157:00 amRNSAGM Trading Update
13th Apr 20153:22 pmRNSDirector/PDMR Shareholding
10th Apr 20159:30 amRNSAnnual Report and Notice of AGM
31st Mar 20159:26 amRNSDirector/PDMR Shareholding
30th Mar 201510:55 amRNSHolding(s) in Company
27th Mar 20153:32 pmRNSHolding(s) in Company
23rd Mar 20158:40 amRNSHolding(s) in Company
17th Mar 20157:00 amRNSFinal Results
11th Mar 20153:51 pmRNSNew venture with China-based King Lai Group
16th Jan 20154:18 pmRNSNotification of Major Interest in Shares
9th Jan 20158:47 amRNSHolding(s) in Company
7th Jan 20157:00 amRNSTrading Update
7th Nov 20147:00 amRNSInterim Management Statement
20th Oct 20147:01 amRNSDirector Declaration
6th Oct 20142:07 pmRNSDirector/PDMR Shareholding
25th Sep 20147:00 amRNSAppointments of Non-executive Directors
19th Sep 201410:31 amRNSHolding(s) in Company
19th Sep 201410:30 amRNSHolding(s) in Company
17th Sep 20149:45 amRNSDirector/PDMR Shareholding
17th Sep 20149:41 amRNSTotal Voting Rights
16th Sep 20144:45 pmRNSHolding(s) in Company
12th Sep 20147:00 amRNSPlacing to raise approximately £8.8m
12th Aug 20147:00 amRNSHalf Yearly Report
29th Jul 201411:17 amRNSHolding(s) in Company
30th Jun 20147:00 amRNSTrading Statement
20th May 201412:59 pmRNSResult of AGM
19th May 20147:00 amRNSAGM Statement and Interim Management Statement
13th May 20143:31 pmRNSDirectorate Change
22nd Apr 201412:41 pmRNSUnilever to use MuCell technology for Dove bottles
14th Apr 20144:04 pmRNS2013 Annual Report & Accounts and Notice of AGM
9th Apr 20149:06 amRNSDirector/PDMR Shareholding
8th Apr 20148:16 amRNSDirector/PDMR Shareholding
18th Mar 20147:00 amRNSFinal Results
15th Jan 20147:00 amRNSTrading Update
19th Nov 20134:19 pmRNSHolding(s) in Company
23rd Oct 20137:00 amRNSTrading Update and Interim Management Statement
17th Oct 20131:21 pmRNSHolding(s) in Company
1st Oct 20132:13 pmRNSDirector Declaration
21st Aug 201312:15 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.